What are the appropriate dosing regimens for amoxicillin and cephalexin in an adult with chronic kidney disease stage 5 (eGFR < 15 mL/min/1.73 m²) undergoing intermittent hemodialysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dosing Amoxicillin and Cephalexin in CKD Stage 5 on Hemodialysis

For adults with CKD stage 5 (eGFR < 15 mL/min/1.73 m²) on intermittent hemodialysis, amoxicillin should be dosed at 250-500 mg every 24 hours (depending on infection severity) with an additional dose after each dialysis session, while cephalexin requires no specific dose reduction but should be given after dialysis on dialysis days.

Amoxicillin Dosing

Standard Approach for Hemodialysis Patients

The FDA label for amoxicillin provides clear guidance: patients on hemodialysis should receive 500 mg or 250 mg every 24 hours depending on infection severity, with an additional dose both during and at the end of dialysis 1. This recommendation is reinforced by multiple guidelines addressing renal dosing 2.

Key pharmacokinetic considerations:

  • Amoxicillin is approximately 68% renally excreted in patients with normal kidney function 3
  • Hemodialysis significantly removes amoxicillin, with extraction ratios around 0.44 4
  • The serum half-life extends from 71 minutes (normal function) to approximately 16 hours in anephric patients 3
  • Post-dialysis supplementation is essential because dialysis reduces serum concentrations substantially 4

Practical Dosing Algorithm

For mild-to-moderate infections:

  • 250 mg every 24 hours
  • Give 250 mg after each dialysis session

For severe infections:

  • 500 mg every 24 hours
  • Give 500 mg after each dialysis session

Timing: Administer the scheduled dose immediately after hemodialysis to avoid drug loss during dialysis and facilitate directly observed therapy 5.

Cephalexin Dosing

Standard Approach for Hemodialysis Patients

The FDA label for cephalexin does not specify dose adjustments for hemodialysis patients, stating only that "patients with impaired renal function do not generally require a reduction in dose unless the impairment is severe" 6. However, research evidence demonstrates that hemodialysis reduces cephalexin serum concentrations by 58% over a 6-hour session 7.

Practical approach:

  • Standard adult doses (250-500 mg every 6 hours, or 500 mg every 12 hours for appropriate indications) can be used 6
  • Administer doses after dialysis on dialysis days to prevent drug loss
  • Monitor clinical response, as cephalexin achieves adequate urinary concentrations even in severe renal impairment for treating susceptible organisms 7

Important Caveats

For both antibiotics:

  1. Avoid the 875 mg amoxicillin dose in patients with GFR < 30 mL/min 1

  2. Infection severity matters: The choice between 250 mg vs 500 mg for amoxicillin depends on infection severity and causative organism susceptibility 1

  3. Prophylactic dosing differs: For antibiotic prophylaxis (e.g., dental procedures in high-risk patients), guidelines recommend 2 g amoxicillin orally 1 hour before the procedure for hemodialysis patients, or cephalexin as an alternative for penicillin-allergic patients 8. This single prophylactic dose does not require the same adjustments as therapeutic dosing.

  4. Accumulation risk: Research shows that the amoxicillin-to-clavulanic acid ratio increases dramatically in hemodialysis patients (from 4.9 in normal function to 14.7 on dialysis), indicating differential accumulation 9. While your question asks about amoxicillin alone, this highlights the importance of monitoring for drug accumulation in severe renal impairment.

  5. Nephrotoxicity concerns: While penicillins like amoxicillin have low nephrotoxicity, high doses (particularly benzylpenicillin > 6 g/day) can cause neurotoxicity when GFR < 15 mL/min 10. Standard amoxicillin doses are generally safe, but crystalluria risk exists with high doses 11.

Clinical Monitoring

  • Assess clinical response at 48-72 hours 1
  • For streptococcal infections, continue treatment for at least 10 days 1, 6
  • Consider therapeutic drug monitoring if available, particularly for severe infections or if clinical response is suboptimal
  • Ensure adequate hydration to prevent crystalluria, especially with higher amoxicillin doses 11

References

Related Questions

What is the appropriate amoxicillin dose for a urinary tract infection in a patient with chronic kidney disease (CKD) and a glomerular filtration rate of 52 mL/min?
What is the appropriate amoxicillin dosing for an adult with an estimated glomerular filtration rate of 49 mL/min/1.73 m²?
What is the appropriate dosing of Augmentin (amoxicillin‑clavulanate) in patients with renal failure or impaired renal function?
What alternative medication can be used for a patient with chronic kidney disease who cannot receive amoxicillin?
In a 62‑year‑old woman with chronic kidney disease (glomerular filtration rate 24 mL/min) who recently completed azithromycin (Z‑Pak) for a respiratory infection and now feels febrile but has stable vital signs, a normal chest radiograph, and neutrophilic leukocytosis, how should she be managed?
What is the safest and most effective treatment for eyelid atopic dermatitis in a pregnant patient?
Is a 2.1 cm right renal cortical cyst clinically significant, and should I be referred to a nephrologist?
What is the appropriate cefuroxime (Zinnat) dosing regimen for an adult with chronic kidney disease stage 5 (eGFR < 15 mL/min/1.73 m²), including adjustments for intermittent hemodialysis?
What is the recommended treatment regimen for chronic cystitis, including acute therapy and prophylaxis?
How do Lokelma (sodium zirconium cyclosilicate) and Kayexalate (sodium polystyrene sulfonate) compare in the management of hyperkalemia?
In a teenage athlete with an avulsion fracture of the elbow, should surgery be performed or can it be managed non‑operatively?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.